Ryusei Matsuyama Selected Research

Transplantation

5/2016	Orthotopic Implantation of Intact Tumor Tissue Leads to Metastasis of OCUM-2MD3 Human Gastric Cancer in Nude Mice Visualized in Real Time by Intravital Fluorescence Imaging.
2/2016	Successful multidisciplinary treatment of refractory cytomegalovirus infection after living donor liver transplantation using mixed lymphocyte reactions: report of a case.
12/2012	The current diagnosis and treatment of benign biliary stricture.
5/2012	Emergency versus elective living-donor liver transplantation: a comparison of a single center analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryusei Matsuyama Research Topics

Disease

65	Neoplasms (Cancer) 01/2024 - 02/2006
26	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2006
24	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 05/2007
12	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2020
11	Adenocarcinoma 02/2021 - 05/2007
8	Inflammation (Inflammations) 01/2024 - 04/2015
8	Lymphatic Metastasis 04/2023 - 08/2016
6	Klatskin Tumor 06/2024 - 05/2012
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2006
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2023 - 02/2015
5	Cholangiocarcinoma 02/2023 - 08/2019
5	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 12/2013
5	Cholangitis 07/2021 - 05/2013
5	Liver Failure 05/2020 - 11/2007
5	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 07/2016
4	Triple Negative Breast Neoplasms 05/2021 - 09/2020
4	Infections 02/2016 - 10/2013
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 01/2014
3	Pathologic Constriction (Stenosis) 04/2016 - 12/2012
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2023 - 12/2020
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2021 - 01/2017
2	Sepsis (Septicemia) 03/2021 - 10/2013
2	Gallbladder Neoplasms (Gallbladder Cancer) 03/2021 - 03/2021
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 07/2006
2	Hemorrhage 05/2020 - 12/2015
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2018 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 03/2016 - 01/2015
2	Carcinoma (Carcinomatosis) 05/2008 - 05/2007
1	Papillary Adenocarcinoma 03/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 12/2021

Drug/Important Bio-Agent (IBA)

14	Gemcitabine FDA Link 04/2023 - 05/2007
13	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2017
10	Proteins (Proteins, Gene)FDA Link 02/2022 - 05/2008
9	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 03/2016
5	InterferonsIBA 07/2022 - 12/2013
5	Methionine (L-Methionine)FDA Link 04/2022 - 11/2020
4	Oxygen (Dioxygen)IBA 07/2022 - 05/2012
4	L-methionine gamma-lyaseIBA 01/2022 - 01/2018
4	palbociclibIBA 01/2021 - 07/2016
3	Histones (Histone)IBA 04/2022 - 12/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 05/2008
3	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2017
3	PlasticsIBA 12/2020 - 02/2015
3	Docetaxel (Taxotere)FDA Link 09/2019 - 11/2017
3	pazopanib FDA Link 01/2019 - 01/2015
2	Carcinoembryonic AntigenIBA 01/2024 - 07/2022
2	Complement System Proteins (Complement)IBA 07/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 07/2022 - 01/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 07/2022 - 01/2021
2	Lysine (L-Lysine)FDA Link 04/2022 - 01/2022
2	BismuthIBA 04/2022 - 12/2012
2	Semaphorin-3AIBA 02/2022 - 12/2013
2	BilirubinIBA 08/2021 - 08/2019
2	SolutionsIBA 02/2021 - 01/2020
2	AntigensIBA 02/2021 - 11/2020
2	Immune Checkpoint ProteinsIBA 01/2021 - 12/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2020 - 11/2017
2	Immune Checkpoint InhibitorsIBA 10/2020 - 01/2020
2	Estrogen ReceptorsIBA 04/2020 - 01/2020
2	human ERBB2 proteinIBA 04/2020 - 01/2020
2	regorafenibIBA 01/2019 - 01/2018
2	Imatinib Mesylate (Gleevec)FDA Link 06/2018 - 01/2018
2	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2018 - 07/2016
2	Messenger RNA (mRNA)IBA 01/2018 - 07/2006
2	Cyclin-Dependent Kinase 4IBA 11/2017 - 07/2016
2	Insulin (Novolin)FDA Link 11/2017 - 07/2016
2	EndotoxinsIBA 02/2017 - 02/2014
2	Thymidylate SynthaseIBA 01/2017 - 07/2006
2	Equilibrative Nucleoside Transporter 1IBA 01/2017 - 05/2007
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2017 - 07/2006
2	Fluorouracil (Carac)FDA LinkGeneric 12/2013 - 07/2006
2	Small Interfering RNA (siRNA)IBA 12/2013 - 05/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2013 - 05/2012
2	Complementary DNA (cDNA)IBA 07/2011 - 07/2006
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2023
1	Hemoglobins (Hemoglobin)IBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022
1	Hormones (Hormone)IBA 02/2022
1	Calcibiotic Root Canal SealerIBA 01/2022

Therapy/Procedure

28	Therapeutics 02/2024 - 02/2006
27	Neoadjuvant Therapy 04/2023 - 01/2014
23	Drug Therapy (Chemotherapy) 06/2024 - 07/2006
16	Hepatectomy 02/2024 - 11/2007
7	Pancreaticoduodenectomy 01/2021 - 01/2014
6	Stents 07/2021 - 12/2012
5	Liver Transplantation 03/2021 - 12/2012
4	Radiotherapy 04/2023 - 08/2019
4	Pancreatectomy 01/2023 - 08/2019
4	Adjuvant Chemotherapy 05/2022 - 08/2016
4	Transplantation 05/2016 - 05/2012
3	Oral Administration 06/2018 - 01/2018
2	Length of Stay 01/2023 - 10/2013
2	Absorbable Gelatin Sponge 12/2020 - 01/2014
2	Immunotherapy 05/2020 - 09/2017
2	Lymph Node Excision (Lymph Node Dissection) 09/2019 - 12/2015
2	Laparotomy 06/2018 - 01/2018
1	Chemoradiotherapy 06/2024
1	Subcutaneous Injections 02/2022